Clinical Trials Browser

Lung Neoplasms × pazopanib × Clear all

NCT01253369 2019-04-23

Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Completed

33 enrolled 8 charts

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Phase 1 Terminated

31 enrolled 12 charts

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT01262820 2017-03-07

LCCC0921

Phase 2 Completed

15 enrolled 10 charts

Lung Neoplasms

NCT01027598 2016-01-29

Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

Phase 2 Completed

202 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01060514 2013-10-30

Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer

Phase 1 Terminated

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms